Tara Lech/thrombosis.org
Feb 21, 2026, 12:41
Tara Lech: New Guidelines for Comprehensive, Evidence Based Management of PE
Tara Lech, Director of Anticoagulation Services at Beth Israel Lahey Health and Member Board of Directors at Anticoagulation Forum, shared a post LinkedIn:
“New guidelines for comprehensive, evidence based management of PE
Collaborated on and endorsed by 8 societies
What you will find:
- Acute PE Clinical Categories (A-E)
- Clearly defined risk factors to screen for during a targeted history and physical examination
- Overview of an effective PERT Team
- LMWH preferred over unfractionated Heparin for most patients
- Considerations for special populations (Obesity, Thrombotic APS, Brain Tumors, CKD, Pregnancy, Breastfeeding, Chronic Liver Disease)
- Recommendations for timing and utility of LMWH levels, noting Class III
Recommendation: No Benefit for most patients with acute PE ”
Stay updated with Hemostasis Today.
-
Jul 2, 2026, 11:52Praveen Kumar Tirlangi: A New Mechanism of Bleeding in Kyasanur Forest Disease
-
Jul 2, 2026, 11:17Heghine Khachatryan: Novel Biomarkers for Cancer-Associated Thrombosis
-
Jul 2, 2026, 11:17Neeraj Jain: Maharashtra Is Setting the Pace for Integrated Hemoglobinopathy Care
-
Jul 2, 2026, 11:11Safaa Hilal: Improving Postpartum Hemorrhage Outcomes Through Early Warning Scores
-
Jul 2, 2026, 11:10Maria Khan Junaidi: How Age Influences Intracerebral Hemorrhage Outcomes
-
Jul 2, 2026, 10:51Faces of Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jul 2, 2026, 10:44Priya Sriskandarajah: Understanding Anemia of Chronic Disease in Clinical Practice
-
Jul 2, 2026, 10:42Flora Peyvandi: Germline-Targeting Vaccines for HIV
-
Jul 2, 2026, 10:29Nisar Ahmed: The Evolution of Anticoagulation Therapy